Literature DB >> 31617267

A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion.

Sadatoshi Tsuzuki1, Tatsuki R Kataoka1, Hiroaki Ito1, Chiyuki Ueshima1, Satsuki Asai1, Hideaki Yokoo2, Hironori Haga1.   

Abstract

Renal cell carcinoma unclassified with medullary phenotype (RCCU-MP) is a rare variant of renal medullary carcinoma (RMC) characterized by loss of SMARCB1 (INI1 / SNF5 / BAF47) protein expression in patients without sickle cell trait. Here, we report a case of RCCU-MP in a Japanese patient who had experienced colon cancer 13 years ago, gastric cancer 11 years ago and lung cancer 9 years ago and had received hemodialysis for 15 years. This is the first report of RCCU-MP in Japan. The patient was not of African descent, and did not have SCT or any other hereditary blood abnormality typical of RMC. The tumor was located in the left kidney, and was composed histologically of rhabdoid cells with marked lymphocyte infiltration; it was immunohistochemically negative for SMARCB1. We were, however, unable to detect mutation in the SMARCB1 gene, reduced messengerRNA expression, or deletion or translocation of chromosome 22, where the SMARCB1 gene is located. These results suggest that RCCU-MP may not involve the hemizygous loss of this gene noted in typical RMC cases.
© 2019 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  SMARCB1; renal cell carcinoma unclassified with medullary phenotype; renal medullary carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31617267     DOI: 10.1111/pin.12858

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Case Report: A Case of Renal Cell Carcinoma Unclassified With Medullary Phenotype Exhibiting a Favorable Response to Combined Immune Checkpoint Blockade.

Authors:  Masashi Takeda; Soki Kashima; Yasushi Fuchigami; Takayuki Yoshino; Tatsuki R Kataoka; Toshinari Yamasaki; Hiroshi Kagamu; Takashi Kobayashi; Shusuke Akamatsu
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

2.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

3.  Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma.

Authors:  Marina Valeri; Miriam Cieri; Grazia Maria Elefante; Camilla De Carlo; Noemi Rudini; Giovanni Lughezzani; Nicolò Maria Buffi; Luigi Maria Terracciano; Piergiuseppe Colombo
Journal:  Front Med (Lausanne)       Date:  2022-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.